Skip to main content


Neuropsychiatric complaints: our priority

Neuropsychiatric complaints: our priority

Many neuropsychiatric complaints are amongst the most destructive and complex illnesses. Our mission is to tackle this destruction in illnesses such as schizophrenia. Janssen has been committed to fighting schizophrenia for over 55 years. Two antipsychotics are on the list of Essential Medicines of the World Health Organization. Tackling the illness requires a multidisciplinary approach.

Research into the causes and treatment of schizophrenia is still in progress today. Sonja Willems, managing director for the Benelux, explains: ‘There are some new therapies in clinical development to treat symptoms of schizophrenia. We’re trying to get a better grasp of the underlying causes and improve results and therapy with long-acting medication. Thanks to innovative technology, we can now supply patients and healthcare providers with a long-acting injection of three months.’

Multidisciplinary approach

Research is certainly only part of the bigger puzzle. Apart from pharmacological treatment, we’re also striving for optimum care. And so, for example, there is a platform that we’ve developed to send patients a text message if they haven’t called in for an injection. We also support doctors and healthcare professionals in the field of medical education, and we have a program called Care4Today™ Mental Health Solutions in which healthcare providers help patients take control of their illness and their lives, set personal goals, and work toward recovery.


Sonja comments: ‘Apart from discomfort through symptoms and limitations, stigmatization is one of the most decisive factors in the experience of schizophrenia patients and in that of their families. There are major misunderstandings and antiquated knowledge about the illness and the people who suffer from it.’ Together with agencies such as Similes, DENK, Te Gek!?, VDIP, Zorgnet-Icuro, Awel, VLESP, and Agentschap Zorg en Gezondheid, Janssen has launched the Flemish awareness campaign under the Dutch title Doe Eens Goed Gek. The goal is to reduce ignorance and social isolation, which, unfortunately, is often the result of a psychotic experience as a young adult.

Furthermore, the Labyrinth Psychotica helps people to understand better what someone can experience during a psychosis. The reality of a psychosis is imitated with the help of a portable headset. Sonja concludes: ‘This is how we hope to contribute to a better understanding and better patient support.’